International students explore China’s medical innovations in Liaoning province during last month’s My China Surprise program ...
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
AeroRx Announces $21M Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage ...
SHE was described as a “normal, everyday, next-door neighbour mum” – but behind closed doors Hope Ybarra was committing ...
1don MSN
I thought my symptom was a common condition... but tests revealed a giant tumor was suffocating me
A woman in her early 20s, from the UK, who suspected her breathing issues were due to a common condition actually had a giant ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
A chronic cough can be due to many things from asthma to post-COVID-19. Here's how to figure out why you can't stop coughing ...
Long-term treatment with Tyvaso DPI is safe and effective in adults with PAH who were previously on Tyvaso, according to ...
Dermatologists explain the science behind wildly popular treatments like red light therapy, which is now available at home—for a steep price. Full-face LED masks like this one can cost up to several ...
Yasmine Wasfi, M.D., Ph.D., FCCP Promoted to CMO, Effective Immediately ---- CMO Ray Pratt, M.D., FACP to Transition to Senior Medical Advisor --LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: ...
Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback